Dyslipidaemia. When to use combination therapy?

Abstract

Obviously, only complex modification of dyslipidaemia, not only attainment of target total and LDL-cholesterol levels, is a cornerstone of strategies to reduce risk of atherosclerotic vascular complications.

Keywords

• Statins
• fibrates
• niacin
• resin
• ezetimibe
• lipid-lowering drugs combination
• cardiovascular risk